Genaissance May Get Nasdaq Warning Letter as Stock Hovers Below $1 for 30 Days | GenomeWeb

NEW YORK, Sept. 18 - Genaissance Pharmaceuticals may soon receive a warning from the Nasdaq exchange for failing to keep its share price above $1 for 30 consecutive trading days.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.